With plans to raise roughly $256.9 million, Cayman Islands-based AMR Resources Acquisition Corp. filed for an initial public offering on Friday. The blank-check company intends to leverage its Nasdaq debut to hunt for acquisition targets within the critical minerals sector, spanning everything from exploration to recycling.
A modest recovery in precious metals markets offered a reprieve for raw material producers this week, even as silver futures finalized their steepest weekly decline since 2018. The rebound comes alongside a structural shift at BHP Group, which is splitting its regional management to accelerate growth across the Americas.
Threats of escalating trade tensions between the United States and Europe sent industrial and transportation stocks into a slump Friday. The market reaction followed a week of conflicting economic signals, as traders weighed cooling inflation indicators against the prospect of a renewed standoff over international tech taxation.
Under a court-mandated restructuring, Corporacion America Airports is set to participate in a fast-track tender to acquire the remaining stake in Inframerica Concessionaria do Aeroporto de Brasilia. The move follows an amendment agreement with Brazilian authorities that effectively clears the path for the firm to consolidate its ownership of the airport.
Months after entering Chapter 11 bankruptcy, Yellow Corp. has confirmed a significant security breach. On March 27, 2025, unauthorized actors infiltrated the company's network and exfiltrated sensitive files, forcing the defunct carrier to issue a public notice because it could no longer verify contact information for the victims.
A broader market rotation into underperforming sectors sent health-care stocks climbing this week. Investors moved away from high-growth leaders, favoring pharmaceutical firms that showed promise in new drug development and regulatory milestones, even as antitrust scrutiny and authorization hurdles complicated the landscape for other industry players.
Falling oil futures are providing a rare tailwind for the consumer sector, as the prospect of cheaper gasoline helps stabilize sentiment after a period of historic pessimism. Investors are recalibrating their expectations for retail spending power while simultaneously weighing new regulatory scrutiny hitting major European e-commerce players.
Universe Pharmaceuticals has finalized an agreement to acquire Best Praise International Limited for $10.8 million in stock. The move secures control over five Chinese patents, marking a strategic pivot for the company as it seeks to expand its footprint in neurodegenerative research and advanced drug delivery systems.
Biotechnology firm Scancell Holdings has entered preliminary negotiations to acquire Neuphoria Therapeutics, a move that would facilitate Scancell’s debut on the Nasdaq exchange. The companies confirmed the ongoing discussions late Friday, though both sides cautioned that a final agreement remains subject to further deliberation and regulatory approval.
The Food and Drug Administration has blocked approval for LNTH-2501, a diagnostic agent intended for neuroendocrine tumor detection, citing unresolved manufacturing deficiencies at a third-party facility. Lantheus Holdings confirmed the setback Friday, marking a significant hurdle for one of its primary late-stage oncology candidates.
A $50 million transaction has effectively removed City Center from Kite Realty Group’s portfolio. The 1.1 million-square-foot mixed-use asset in White Plains, New York, anchored by major retail tenants Target and Shop Rite, was offloaded as the company continues to refine its holdings through an aggressive capital recycling strategy.
For the roughly 30% of psoriasis patients who develop symptoms before turning 18, relief options have expanded. The FDA has officially cleared AbbVie’s Skyrizi, known chemically as risankizumab-rzaa, for pediatric use, marking a shift in how clinicians can manage moderate-to-severe plaque psoriasis and active psoriatic arthritis in younger populations.
Effective July 1, Kroger Chairman Ronald Sargent will step away from his employee status at the supermarket chain. While vacating his executive duties, the former Staples chief executive will maintain his presence on the board, transitioning into a non-executive role to continue his oversight of the company.
Universe Pharmaceuticals has reached an agreement to acquire Best Praise International Limited in an all-stock transaction valued at $10.8 million. The move, which involves issuing 4.8 million shares of common stock, aims to bolster the company’s intellectual property portfolio ahead of the deal's expected third-quarter closing.
A 9.8% jump in after-hours trading greeted Healthcare Triangle on Friday, as the company moved to resolve a stalled asset acquisition. The surge follows a new securities exchange agreement aimed at correcting a previous deal with SecureKloud Technologies that left the latter unable to convert its preferred stock holdings.
West Texas Intermediate futures dropped 3.7% to settle at $69.23 a barrel on Friday, marking the lowest price point since late February. Despite rising geopolitical tensions in the Strait of Hormuz and reports of renewed military strikes, the energy sector failed to find support as market sentiment shifted toward supply recovery.
With a strategic focus on expanding its international software footprint, Hong Kong-based service provider Gold Stone Technical has officially filed for an initial public offering. The firm aims to raise roughly $28.1 million by listing 6.25 million shares, positioning itself for a growth push across global technology markets.
Growth across the Tenth District’s service sector decelerated in June as the Kansas City Federal Reserve’s composite index fell to 5, down from 10 in May. While the reading remains in positive territory, the cooling reflects a broader softening in retail trade and transportation services across the seven-state region.
Shares of Solana Beach-based Aevex climbed 10% to $16.97 midday Friday, reversing a recent slide after the defense contractor confirmed its upcoming entry into the Russell 2000 Index. The transition, scheduled for June 29, marks a significant milestone for the firm just months after its initial public offering.
Oil tankers are flowing through the Strait of Hormuz without disruption, cooling regional tensions that briefly spiked on Thursday. The renewed stability in the critical waterway has sent global crude benchmarks tumbling, putting the front-month U.S. contract on track to settle below $70 per barrel for the first time since March.
Investors pushed FactSet Research Systems shares up 10% on Friday to $229.50, reacting to the financial data firm's integration of portfolio analytics into its AI-driven model context protocol. The expansion aims to streamline how buy-side professionals interact with complex risk and performance data through conversational interfaces.
Kyivstar’s parent company, Veon, has signed a memorandum of understanding with the Ukrainian Ministry of Economy to construct a dedicated artificial-intelligence data center. This collaboration marks a strategic push to bolster the nation's technological sovereignty while integrating advanced computing power into its war-time digital economy.
Darren Guidry will take the helm as president of Home Bancorp starting July 1, a move that allows John Bordelon to narrow his focus as chief executive. The shift marks a structural pivot for the parent company of Home Bank, aimed at delineating strategic oversight from day-to-day execution.
Shares of Opus Genetics climbed 9.9% to $4.09 during Friday morning trading after the biopharmaceutical firm secured a spot across three major benchmarks. The company will join the Russell 3000, Russell 2000, and Russell Microcap indexes, signaling a notable shift in its market profile ahead of the upcoming rebalancing.
Investors pushed Xunlei shares up 9% to $5.50 on Friday morning after the technology firm authorized a new $20 million repurchase program. The initiative, set to begin July 1, allows the company to buy back American Depositary Shares or common stock over the next 12 months using its existing cash reserves.
Shares of Omeros Corporation plunged 25% to $8 in premarket trading Friday after the European Medicines Agency delivered a negative opinion on the company’s lead drug, narsoplimab. The decision stalls the biotech firm’s efforts to introduce its treatment for a lethal post-transplant complication into the European market.
After four years at the helm of the world's largest automotive supplier, Stefan Hartung is stepping down as chairman of Robert Bosch. The leadership transition, initiated at Hartung's own request, marks a pivotal shift for the German engineering giant as it navigates a rapidly evolving global manufacturing landscape.
Nevada-focused miner i-80 Gold has scrapped a restrictive sales agreement with Vox Royalty, a strategic move intended to reclaim control over its production output. By eliminating a fixed-price delivery obligation for its Granite Creek and Ruby Hill properties, the company aims to capitalize on current market valuations rather than historical benchmarks.
Shares of Apogee Enterprises climbed 12% to $47.60 in premarket trading after the architectural products manufacturer reported a sharp shift to profitability. Despite a slight dip in quarterly revenue, the company’s aggressive cost-cutting measures successfully propelled its bottom line out of the previous year’s red ink.
Shares of Acadia Pharmaceuticals climbed 13% to $27.30 in premarket trading Friday, reacting to a favorable recommendation from the European Medicines Agency for its Rett syndrome treatment, Daybu. The decision marks a critical step toward securing marketing authorization for the neurodevelopmental drug across the European Union.
